BrainsWay Announces Positive OCD Coverage Policy by Blue Cross Blue Shield® Licensee HCSC
HCSC Covers Approximately 17 Million Members Across Five States CRESSKILL, N.J. and JERUSALEM, Israel, June 2, 2021 (GLOBE NEWSWIRE) –...
top of page
News & Events
Jun 1, 2021
BrainsWay Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administrative Cont
BrainsWay Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administrative Contractor Palmetto GBA, Administrator of...
May 24, 2021
BrainsWay Announces First of its Kind Positive Coverage Policy by Centene for the Treatment of OCD U
BrainsWay Announces First of its Kind Positive Coverage Policy by Centene for the Treatment of OCD Utilizing Deep TMS™ CRESSKILL, N.J....
May 20, 2021
BrainsWay Reports First Quarter 2021 Financial Results and Operational Highlights
*Note, the numbers contained herein reflect certain updates to the previous unaudited financial results for the first Quarter 2021,...
May 6, 2021
BrainsWay to Report First Quarter 2021 Financial Results on May 20, 2021
CRESSKILL, N.J. and JERUSALEM, Israel, May 6, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader...
May 5, 2021
BrainsWay Announces Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Of
BrainsWay Announces Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Officer CRESSKILL, N.J. and JERUSALEM,...
May 4, 2021
BrainsWay Announces Social Media Sweepstakes to Celebrate Mental Health Awareness Month
The Sweepstakes, demonstrating how Deep Transcranial Magnetic Stimulation (Deep TMS) can fit into an average day, offers participants a...
May 3, 2021
BrainsWay to Ring NASDAQ Closing Bell to Highlight May as Mental Health Awareness Month
CRESSKILL, N.J. and JERUSALEM, May 03, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a...
Apr 29, 2021
BrainsWay Announces Launch of Noninvasive Treatment for Smoking Addiction to U.S. Providers
Patients in areas across the country now have access to Deep Transcranial Magnetic Stimulation (Deep TMS) therapy as an aid for...
Apr 26, 2021
BrainsWay Receives FDA Clearance for Three-Minute Theta Burst Treatment Protocol for Major Depressiv
BrainsWay Receives FDA Clearance for Three-Minute Theta Burst Treatment Protocol for Major Depressive Disorder Shorter Protocol Further...
Apr 14, 2021
BrainsWay Announces 100,000 Patients Treated with Deep Transcranial Magnetic Stimulation (Deep TMS)
The FDA cleared technology is a noninvasive treatment for depression, OCD, and smoking addiction CRESSKILL, N.J. and JERUSALEM, Israel,...
Mar 24, 2021
BrainsWay Reports Fourth Quarter and Full-Year 2020 Financial Results and Operational Highlights
Conference call to be held tomorrow, March 25, 2021, at 8:30 AM ET CRESSKILL, N.J. and JERUSALEM, Israel, March 24, 2021 (GLOBE NEWSWIRE)...
Mar 11, 2021
BrainsWay to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021
CRESSKILL, N.J., March 11, 2020 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced...
Mar 8, 2021
BrainsWay to Present at the Oppenheimer 31st Annual Healthcare Conference
CRESSKILL, N.J. and JERUSALEM, Israel, March 8, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...
Mar 1, 2021
BrainsWay Ltd. Announces Closing of $45.2 Million Underwritten Public Offering of American Depositar
BrainsWay Ltd. Announces Closing of $45.2 Million Underwritten Public Offering of American Depositary Shares Including Full Exercise of...
Feb 23, 2021
BrainsWay Ltd. Announces Pricing of $39,287,000 Underwritten Offering of American Depositary Shares
CRESSKILL, N.J. and JERUSALEM, Feb. 23, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a...
Feb 22, 2021
BrainsWay Ltd. Announces Proposed Public Offering of American Depositary Shares
CRESSKILL, N.J. and JERUSALEM, Feb. 22, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a...
Feb 16, 2021
BrainsWay Enhances Commercial Leadership Team with the Addition of Fran Hackett as Vice President of
BrainsWay Enhances Commercial Leadership Team with the Addition of Fran Hackett as Vice President of North American Sales CRESSKILL, N.J....
Feb 16, 2021
BrainsWay Reports Preliminary Record Fourth Quarter Revenue and Full-Year 2020 Financial Results
CRESSKILL, N.J. and JERUSALEM, Israel, February 16, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the...
Jan 25, 2021
BrainsWay Signs Exclusive Distribution Agreement with Gaelan Medical Trade LLC
CRESSKILL, N.J. and JERUSALEM, Israel, Jan. 25, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the...
bottom of page